Effects of Shockwave Therapy Versus Radiofrequency

September 28, 2020 updated by: Andreia Noites, Escola Superior de Tecnologia da Saúde do Porto

Effect of an Aerobic Exercise Program Associated With Shock Wave Therapy Versus Radiofrequency on Skin and Subcutaneous Tissue: Randomized Controlled Study

The main objective of this study is to compare the effect of 6 sessions of shock wave therapy versus radiofrequency followed by a protocol of moderate aerobic exercise, in the reduction of adiposity and abdominal flaccidity, in females between 18 and 60 years old. As a secondary objective, it is intended to understand the mechanism of fat mobilization by these two therapies.

Study Overview

Detailed Description

With the increasing awareness of the population regarding the high rate of obesity and the number of deaths per year as a result of being overweight, treatments for reducing measures are increasingly sought.

The evidence shows that the accumulation of fat located in the abdominal region is a risk factor for dyslipidemia and arterial hypertension, and a reduction in waist circumference can reduce the potential risk of cardiovascular disease.

In addition to this concern, with the aging of the population and changes in body dimensions due to pregnancy or to a weight loss process, body flaccidity is also a growing cosmetic complaint, and the result is a less firm and pending skin.

Physical exercise is a very important agent for combating excess weight, with special attention to aerobic physical exercise, which is able to decrease body fat tissue and increase the oxidation of fatty acids by 5 to 10 times more than in resting state. The evidence points out that the exercise prescription to decrease fat mass should focus on a high volume of training (30 to 60 minutes) with moderate intensity (40 to 60% of Heart Rate Reserve), performed regularly and mobilizing large muscle groups.

In order to combat abdominal adiposity, as well as the flaccidity of the region, radiofrequency is presented as a possible complementary strategy.

Radiofrequency is an electromagnetic wave that when applied to skin, generates oscillating magnetic fields that move electrically charged particles producing heat in the tissues. The amount of heat produced is dependent on resistance.

Shock wave therapy consists of the application of high energy acoustic waves whose main characteristic is the production of a high pressure pulse induced in a short period of time. This will generate mechanical pressure waves in the tissues, promoting cavitation, with the formation of gas bubbles in the intervening fluids and an increase in local temperature.

The main objective of this study is to compare the effect of 6 sessions of shock wave therapy versus radiofrequency followed by a protocol of moderate aerobic exercise, in the reduction of adiposity and abdominal flaccidity, in females between 18 and 60 years old. As a secondary objective, it is intended to understand the mechanism of fat mobilization by these two therapies.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Porto
      • Vila Nova de Gaia, Porto, Portugal, 4400-330
        • Andreia Noites

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women aged 18 to 60 years

Exclusion Criteria:

  • smoking and drinking habits;
  • athletes;
  • people with dietary restrictions;
  • participants who have had diets to lose weight in the last 3 months or who will start during the study;
  • pregnant women;
  • in postpartum less than one year;
  • breastfeeding;
  • intending to become pregnant during the study period;
  • patients with electronic or metallic devices (pacemaker, IUD);
  • individuals with metabolic (including dyslipidemias);
  • hematological and renal disorders;
  • individuals with dermatological changes;
  • cardiovascular, respiratory, digestive, orthopedic, rheumatological and oncological pathologies;
  • changes in the immune system or with acute inflammatory processes;
  • changes in sensitivity or subject to medication (anti-coagulants, corticosteroids up to 6 weeks before, non-steroidal anti-inflammatory drugs, antihistamines, diuretics)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: shockwave therapy group
This group performed aerobic exercise just after shock wave therapy in the abdominal region.
The shock wave device corresponds to the BTL-6000 X-Wave TM with a 20mm transmitter multifocal. The parameters used correspond to the pressure set between 2.8 and 3.5 bar, frequency 15 hertz and 3000 pulses per 10x15 cm area. It was used as a means contact gel for ultrasound, reference 033-051. In this procedure the participants found themselves in the supine position, with a pillow under the head and with the bending knees.
EXPERIMENTAL: radiofrequency group
This group performed aerobic exercise just after radiofrequency in the abdominal region.
Radiofrequency protocol - The radiofrequency protocol was performed in dorsal decubitus, with the head elevated at 45 degrees. The application was in capacitive mode, with a 7cm electrode, always in movement. The duration of the application was established in 15 minutes, maintaining the local temperature between 40 to 42 celsius degrees at the epidermis.
ACTIVE_COMPARATOR: control group
This group only performed aerobic exercise.
Aerobic exercise protocol - 40 minutes of aerobic moderate-intensity exercise (45-55% of reserve heart rate) using Karvonen's formula, performed on a cycloergometer. The duration of the exercise was divided into three parts: warm-up (5 minutes); body (30 minutes); and cooling (from 5 to 10 minutes). The entire protocol was monitored through the Polar® brand heart rate monitor and watch.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cutaneous abdominal tissue thickness
Time Frame: Baseline
Measurement of the cutaneous fold by ultrasonography
Baseline
Cutaneous abdominal tissue thickness
Time Frame: 3 weeks after
Measurement of the cutaneous fold by ultrasonography
3 weeks after
Cutaneous abdominal tissue thickness
Time Frame: 6 weeks after
Measurement of the cutaneous fold by ultrasonography
6 weeks after
Subcutaneous abdominal tissue thickness
Time Frame: Baseline
Measurement of the subcutaneous adipose fold by ultrasonography
Baseline
Subcutaneous abdominal tissue thickness
Time Frame: 3 weeks after
Measurement of the subcutaneous adipose fold by ultrasonography
3 weeks after
Subcutaneous abdominal tissue thickness
Time Frame: 6 weeks after
Measurement of the subcutaneous adipose fold by ultrasonography
6 weeks after
Glycerol concentration
Time Frame: Baseline
Blood analysis collection carried out with help from an clinical analysis technician
Baseline
Glycerol concentration
Time Frame: 3 weeks after
Blood analysis collection carried out with help from an clinical analysis technician
3 weeks after
Glycerol concentration
Time Frame: 6 weeks after
Blood analysis collection carried out with help from an clinical analysis technician
6 weeks after
Lipid profile (LDL, HDL and triglyceride concentrations)
Time Frame: Baseline
Blood analysis collection carried out with help from an clinical analysis technician
Baseline
Lipid profile (LDL, HDL and triglyceride concentrations)
Time Frame: 3 weeks after
Blood analysis collection carried out with help from an clinical analysis technician
3 weeks after
Lipid profile (LDL, HDL and triglyceride concentrations)
Time Frame: 6 weeks after
Blood analysis collection carried out with help from an clinical analysis technician
6 weeks after
Perimetry
Time Frame: Baseline
Perimetry consists of measuring circumferences. In this case, of the waist at the navel area, 3 cm below it and in the hip area
Baseline
Perimetry
Time Frame: 3 weeks after
Perimetry consists of measuring circumferences. In this case, of the waist at the navel area, 3 cm below it and in the hip area
3 weeks after
Perimetry
Time Frame: 6 weeks after
Perimetry consists of measuring circumferences. In this case, of the waist at the navel area, 3 cm below it and in the hip area
6 weeks after
Adipometry
Time Frame: Baseline
Adipometry consists of measuring skinfold thickness
Baseline
Adipometry
Time Frame: 3 weeks after
Adipometry consists of measuring skinfold thickness
3 weeks after
Adipometry
Time Frame: 6 weeks after
Adipometry consists of measuring skinfold thickness
6 weeks after
Inflammatory markers concentration (IL6, CRP, TNF)
Time Frame: Baseline
Blood analysis collection carried out with help from an clinical analysis technician
Baseline
Inflammatory markers concentration (IL6, CRP, TNF)
Time Frame: 3 weeks after
Blood analysis collection carried out with help from an clinical analysis technician
3 weeks after
Inflammatory markers concentration (IL6, CRP, TNF)
Time Frame: 6 weeks after
Blood analysis collection carried out with help from an clinical analysis technician
6 weeks after
Nitrous oxide concentration
Time Frame: Baseline
Blood analysis collection carried out with help from an clinical analysis technician
Baseline
Nitrous oxide concentration
Time Frame: 3 weeks after
Blood analysis collection carried out with help from an clinical analysis technician
3 weeks after
Nitrous oxide concentration
Time Frame: 6 weeks after
Blood analysis collection carried out with help from an clinical analysis technician
6 weeks after
Body composition- body mass
Time Frame: Baseline
body mass in kilograms
Baseline
Body composition- body mass
Time Frame: 3 weeks after
body mass in kilograms
3 weeks after
Body composition- body mass
Time Frame: 6 weeks after
body mass in kilograms
6 weeks after
Body composition- muscle mass
Time Frame: Baseline
muscle mass in kilograms
Baseline
Body composition- muscle mass
Time Frame: 3 weeks after
muscle mass in kilograms
3 weeks after
Body composition- muscle mass
Time Frame: 6 weeks after
muscle mass in kilograms
6 weeks after
Body composition- fat mass
Time Frame: Baseline
fat mass in kilograms
Baseline
Body composition- fat mass
Time Frame: 3 weeks after
fat mass in kilograms
3 weeks after
Body composition- fat mass
Time Frame: 6 weeks after
fat mass in kilograms
6 weeks after
Body composition- visceral fat
Time Frame: Baseline
visceral fat
Baseline
Body composition- visceral fat
Time Frame: 3 weeks after
visceral fat
3 weeks after
Body composition- visceral fat
Time Frame: 6 weeks after
visceral fat
6 weeks after
Body composition- fat body areas
Time Frame: Baseline
percentage of fat distributed by body areas
Baseline
Body composition- fat body areas
Time Frame: 3 weeks after
percentage of fat distributed by body areas
3 weeks after
Body composition- fat body areas
Time Frame: 6 weeks after
percentage of fat distributed by body areas
6 weeks after
Thermography
Time Frame: Baseline
Thermography is used to assess the temperature of the skin surface, and it is also possible to suppose changes in blood flow and vascularization with this outcome
Baseline
Thermography
Time Frame: 3 weeks after
Thermography is used to assess the temperature of the skin surface, and it is also possible to suppose changes in blood flow and vascularization with this outcome
3 weeks after
Thermography
Time Frame: 6 weeks after
Thermography is used to assess the temperature of the skin surface, and it is also possible to suppose changes in blood flow and vascularization with this outcome
6 weeks after
Photography
Time Frame: Baseline
Photography is used to compare the before and after images. With these it is possible to evaluate the skin flaccidity and fat
Baseline
Photography
Time Frame: 3 weeks after
Photography is used to compare the before and after images. With these it is possible to evaluate the skin flaccidity and fat
3 weeks after
Photography
Time Frame: 6 weeks after
Photography is used to compare the before and after images. With these it is possible to evaluate the skin flaccidity and fat
6 weeks after

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
skin flaccidity
Time Frame: Baseline
Investigator Assessment Skin Laxity Scoring System - Questionnaire that evaluates skin flaccidity and scores from 0 to 4. (As the subjectivity assessment of this outcome, the investigator who evaluates is blind to the group that the participants are allocated, in order to avoid partial scores)
Baseline
skin flaccidity
Time Frame: 3 weeks after
Investigator Assessment Skin Laxity Scoring System - Questionnaire that evaluates skin flaccidity and scores from 0 to 4. (As the subjectivity assessment of this outcome, the investigator who evaluates is blind to the group that the participants are allocated, in order to avoid partial scores)
3 weeks after
skin flaccidity
Time Frame: 6 weeks after
Investigator Assessment Skin Laxity Scoring System - Questionnaire that evaluates skin flaccidity and scores from 0 to 4. (As the subjectivity assessment of this outcome, the investigator who evaluates is blind to the group that the participants are allocated, in order to avoid partial scores)
6 weeks after
skin flaccidity and localized fat in the abdomen region
Time Frame: Baseline
Satisfaction questionnaire to evaluate the final results according to the participant
Baseline
skin flaccidity and localized fat in the abdomen region
Time Frame: 3 weeks after
Satisfaction questionnaire to evaluate the final results according to the participant
3 weeks after
skin flaccidity and localized fat in the abdomen region
Time Frame: 6 weeks after
Satisfaction questionnaire to evaluate the final results according to the participant
6 weeks after

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 22, 2020

Primary Completion (ACTUAL)

April 25, 2020

Study Completion (ACTUAL)

June 19, 2020

Study Registration Dates

First Submitted

February 18, 2020

First Submitted That Met QC Criteria

February 20, 2020

First Posted (ACTUAL)

February 24, 2020

Study Record Updates

Last Update Posted (ACTUAL)

September 30, 2020

Last Update Submitted That Met QC Criteria

September 28, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AN-009

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Risk Factor

Clinical Trials on Shock wave therapy

Subscribe